Overview

Rivastigmine For Methamphetamine Dependent Individuals

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
Methamphetamine abuse has been steadily increasing over the past decade. Rivastigmine is a medication that may be helpful in treating methamphetamine dependence. The purpose of this study is to evaluate the effectiveness of rivastigmine in treating methamphetamine dependent individuals.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
University of California, Los Angeles
Treatments:
Methamphetamine
Rivastigmine